Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Avishai Abrahami
AddedFeb 13, 2024
UpdatedJun 28, 2026
Avishai Abrahami

Avishai Abrahami

Board Member, Wix.com

CrunchbaseThe Org

Avishai Abrahami's Career

Wix.com
Wix.com

Tel Aviv, Tel Aviv District, IL

Board Member· Board
Beyond Air
Beyond Air

New York City, NY, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Avishai Abrahami's Career

Wix.com
Wix.com
Public$58.5M4.5k2006Tel Aviv, Tel Aviv District, IL
Board Member· Board

Leadership at Wix.com

Yuval CohenYuval CohenBoard Member
Deirdre BigleyDeirdre BigleyBoard Member
Nadav AbrahamiNadav AbrahamiCo-Founder
Gavin PattersonGavin PattersonBoard Member
Mark TluszczMark TluszczBoard Member
Ron GutlerRon GutlerBoard Member
Beyond Air
Beyond Air
Public$69.2M982011New York City, NY, US
Co-Founder

Leadership at Beyond Air

David GreenbergDavid GreenbergCo-Founder
Steve LisiSteve LisiBoard Member
Amir AvnielAmir AvnielBoard Member
Yossef Av-GayYossef Av-GayCo-Founder
Erick LuceraErick LuceraBoard Member
Amir AvnielAmir AvnielCo-Founder

Similar to Beyond Air

Aero TherapeuticsAero TherapeuticsSan Diego, CA, USMedical Devicesest. 2019Aero TherapeuticsSan Diego, CA, US · est. 2019

Aero Therapeutics: Developing respiratory aid devices for low-resource settings.

Seed · $180k6
AirXpandersAirXpandersPalo Alto, CA, USMedical Devicesest. 2005AirXpandersPalo Alto, CA, US · est. 2005

AirXpanders manufactures medical devices for tissue expansion in breast reconstruction.

Public · $150M125
RespirogenRespirogenBoulder, CO, USMedical Devicesest. 2017RespirogenBoulder, CO, US · est. 2017

Respirogen: A biotech firm innovating oxygen delivery with device technology, founded in Boulder, 2017.

Seed · $500k2
Third PoleThird PoleWaltham, MA, USMedical Devicesest. 2014Third PoleWaltham, MA, US · est. 2014

Third Pole, Inc., a Waltham-based manufacturer, develops transformative cardio-pulmonary medical devices.

Series B · $85.8M38

Avishai Abrahami's Co-Investors

Kenny StoneKenny StoneCo-invested · Walnut SeedImmad AkhundImmad AkhundCo-invested · Walnut SeedMichael MaMichael MaCo-invested · Walnut SeedYair AmitYair AmitCo-invested · Walnut SeedMatt WyndoweMatt WyndoweCo-invested · Walnut SeedAlon GamzuAlon GamzuCo-invested · Walnut SeedJoe MontanaJoe MontanaCo-invested · Walnut SeedJames HiltonJames HiltonCo-invested · OpenWeb Series A

Avishai Abrahami's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Avishai Abrahami

Asaf KindlerAsaf KindlerCo-Founder · Snapp BuilderChris TerrellChris TerrellCo-Founder · Wexus TechnologiesChris SavageChris SavageCo-Founder · WistiaAmir ErezAmir ErezCo-Founder · WizcoAdam FrankAdam FrankCo-Founder · Wisio